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Riboswitches are conserved regions within mRNA molecules that bind specific
metabolites and regulate gene expression. TPP-riboswitches, which respond to thiamine
pyrophosphate (TPP), are involved in the regulation of thiamine metabolism in numerous
bacteria. As these regulatory RNAs are often modulating essential biosynthesis pathways
they have become increasingly interesting as promising antibacterial targets. Here,
we describe thiamine analogs containing a central 1,2,3-triazole group to induce
repression of thiM-riboswitch dependent gene expression in different E. coli strains.
Additionally, we show that compound activation is dependent on proteins involved
in the metabolic pathways of thiamine uptake and synthesis. The most promising
molecule, triazolethiamine (TT), shows concentration dependent reporter gene repression
that is dependent on the presence of thiamine kinase ThiK, whereas the effect of
pyrithiamine (PT), a known TPP-riboswitch modulator, is ThiK independent. We further
show that this dependence can be bypassed by triazolethiamine-derivatives that bear
phosphate-mimicking moieties. As triazolethiamine reveals superior activity compared
to pyrithiamine, it represents a very promising starting point for developing novel
antibacterial compounds that target TPP-riboswitches. Riboswitch-targeting compounds
engage diverse endogenous mechanisms to attain in vivo activity. These findings are
of importance for the understanding of compounds that require metabolic activation to
achieve effective riboswitch modulation and they enable the design of novel compound
generations that are independent of endogenous activation mechanisms.
Keywords: riboswitches, triazolethiamine, click-chemistry, metal-chelating compounds, metabolic enzymes
INTRODUCTION
Riboswitches are RNA elements mostly found in the 5′ UTR
of bacterial mRNA that specifically sense the concentration of
a small metabolite. Upon metabolite binding, substantial con-
formational changes occur that ultimately result in an on- or
off-switch of gene expression. These regulatory elements rep-
resent a fundamental new means of controlling cellular pro-
cesses in response to environmental conditions (Breaker, 2011).
Riboswitches often regulate expression of essential genes and
as such they are interesting target structures for the develop-
ment of novel antibiotic compounds (Blount and Breaker, 2006).
Artificial compounds acting successfully on riboswitches have
to meet at least two criteria: (i) they must specifically bind to
the relevant RNA structure and (ii) induce the conformational
changes that finally lead to down- or up-regulation of gene
expression. In recent years synthetic molecules that meet these
criteria have been discovered for several riboswitch classes (Lünse
et al., 2014). One of them is the TPP-riboswitch (Miranda-Rios
et al., 2001; Winkler et al., 2002), which selectively interacts with
thiamine pyrophosphate (TPP) by binding to its pyrimidine moi-
ety through the so-called pyrimidine sensor helix (P2, J2-3, P3) of
the aptamer domain. Conformational changes of the riboswitch
resulting in repression of gene expression are only achieved if
the pyrophosphate group of the ligand is recognized by the
pyrophosphate sensor helix (P4, J4-5, P5, Figure 1A) (Edwards
and Ferre-D’Amare, 2006; Serganov et al., 2006; Thore et al.,
2006). While this riboswitch class has been shown to allow a
greater degree of variation at the position of the thiazole ring,
exemplified by the thiamine analog pyrithiamine (PT, Figure 2A),
the presence of the pyrophosphate moiety is mandatory to inter-
act with and, more importantly, to induce switching of the E. coli
thiM-riboswitch (Winkler et al., 2002; Rentmeister et al., 2007).
This necessity impedes the development of compounds that act
on TPP-riboswitches, since either they cannot passively pass the
cell wall due to the highly charged pyrophosphate moiety or they
cannot efficiently activate the riboswitch if lacking this group.
PT’s in vivo activity most likely relies on hijacking endogenous
metabolic enzymes that phosphorylate exogenously added PT,
thereby yielding the active derivative pyrithiamine pyrophosphate
(PTPP) (Iwashima et al., 1976). In this report we elaborate on a
series of triazolethiamines (TT) that have been shown recently
to act on TPP-riboswitches in vitro, if diphosphorylated yielding
triazolethiamine pyrophosphate (TTPP). We investigated TT-
activity in relation to the length and modification of the alkyl
chain and the presence of endogenous proteins involved in thi-
amine metabolism. We found that the activity of triazolethiamine
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FIGURE 1 | (A) Secondary structure of the aptamer domain of the E. coli
thiM riboswitch and the non-binding thiM riboswitch variant (thiM-Mu),
whose alterations in P2 are shown in green (Mayer et al., 2007). (B)
Schematic drawing of plasmid constructs and screening set-up employed
for evaluating effects of thiamine analogs (compounds) in DH5αZ1 cells or
Keio collection strains. When thiamine is added, it is taken up by the
bacteria and converted to thiamine pyrophosphate, which then acts on the
thiM riboswitch causing a repression of reporter gene expression. Levels of
the reporter gene β-galactosidase are assayed by cell lysis and reaction with
ortho-nitrophenyl β-galactoside (ONPG) (see methods for detailed
procedure).
(TT) depends on the metabolic enzyme thiamine kinase (ThiK)
and thiamine transporters. Most importantly, we demonstrated
that ThiK dependency is bypassed by triazolethiamine-derivatives
that bear phosphate mimicking and metal-ion chelating moieties.
This strategy opens new avenues toward riboswitch activating
compounds, in particular those that rely on phosphate groups to
recognize and switch cognate RNA structures.
MATERIALS AND METHODS
β-GALACTOSIDASE REPORTER GENE ASSAY
For β-galactosidase assays 5ml pre-cultures of DH5αZ1,
BW25113 or Keio deletion strains containing the appropri-
ate plasmid constructs were prepared in LB Lennox standard
medium (lysogeny broth Lennox, 10 g/l tryptone, 5 g/l yeast
extract, 5 g/l NaCl in water) and incubated over night at 37◦C and
155 rpm. Incubation was followed by photometric measurement
of optical density at λ = 600 nm (OD600) and dilution of cells
to an optical density of 0.5. This dilution was used to inoculate
β-galactosidase expression cultures at a ratio of 1:500 in a final
volume of 2 or 4ml in M9 medium (5x M9 medium contain-
ing 15 g/l KH2PO4, 5 g/l NH4Cl, 2.5 g/l NaCl, 30 g/l Na2HPO4)
containing final concentrations of 5mM MgSO4, 0.2 wt% glu-
cose, 0.2μg/μl casamino acids (Difco), and 100μg/ml ampicillin.
Even though vitamin-deprived casamino acids were used, growth
of thiamine auxotrophic strains was observed without addition
of thiamine indicating that a small, but constant amount of thi-
amine must be present in the casamino acid stock. Minimal
inhibitory concentration determinations in casamino acid free
minimal mediumwith separately added amino acids revealed that
at least 1 nM of thiamine is necessary to enable bacterial growth
FIGURE 2 | (A) Chemical structures of thiamine (T), pyrithiamine (PT) and
compounds 1–6 that were assayed for influence on thiM
riboswitch-dependent reporter gene expression and bacterial growth
inhibition. (B) Relative β-galactosidase expression in the presence of either
thiamine (20μM) or compounds 1–6 and pyrithiamine (PT) (500μM) in
E. coli DH5αZ1 pRS414.2 thiM wt. Relative β-galactosidase expression in
the presence of either thiamine (20μM) or compounds 1–5 and
pyrithiamine (PT) (500μM) E. coli DH5αZ1 pRS414.2 thiM-Mu (C). As
compound 6 did not show significant effects in primary screenings (B) it
was not used for further investigations (C). Reporter gene activity is shown
in relation to maximum β-galactosidase expression in DH5αZ1 bacteria (no
addition of thiamine, black bars) and addition of 500μM thiamine yield
maximal reporter gene repression (dark gray bars).
of the thiamine auxotrophs investigated. The expression cultures
contained either 20 or 500μM of thiamine (Sigma), 500μM
pyrithiamine (Sigma) or 500μM of the compounds, respectively.
Controls received neither thiamine, or pyrithiamine nor com-
pounds. If compounds had to be dissolved in DMSO, controls
were supplemented with equal amounts (final DMSO concen-
tration: 1%). The cultures were incubated for 24 h at 37◦C and
150 rpm. After 24 h incubation the optical density was measured.
The cells were centrifuged at 4500 g for 5min and the pellets
were washed twice in 400μl 1x PBS (137mM NaCl, 2.7mM
KCl, 10mM Na2HPO4x2H2O, 2mM KH2PO4, pH 7.4). The pel-
lets were resuspended in 200μl 1x lysis buffer (Reporter Lysis
Buffer, Promega), incubated for 15min at room temperature
and cells were pelleted. Supernatants were used for all follow-
ing steps. 75μl of the respective lysates were mixed with 75μl
of 2x assay buffer (200mM sodium phosphate buffer pH 7.3,
2mM MgCl2, 100mM β-mercaptoethanol, 1.33mg/ml ONPG)
and incubated for 5-15min at 37◦C. The reaction was stopped by
the addition of 250μl 1MNa2CO3 and absorbance at 420 nmwas
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measured immediately using a Nanoquant (Infinite 200, Tecan).
Reporter gene assays were performed in clear, flat bottom 96-well
plates. Miller units were calculated according to the following for-
mula: Miller units = (1000∗OD420)/(OD 600∗incubation time
[min]∗culture volume [L]) and Miller units of controls without
thiamine or compound added were set to 1. Samples were run in
duplicate and experiments were repeated at least three times.
RESULTS
Thiamine analogs that bear a 1,2,3-triazole group instead of
the thiazole heterocyclic moiety as found in thiamine were syn-
thesized and investigated for TPP-riboswitch activation using
a β-galactosidase reporter gene assay (Figure 1B). In this assay
the TPP-riboswitch thiM from E. coli was cloned into the
5′-UTR of β-galactosidase. The DH5αZ1 E. coli strain was
transformed by this plasmid (Simons et al., 1987; Diederich
et al., 1992; Lutz and Bujard, 1997). Due to the thi-1 muta-
tion, DH5αZ1 cells are thiamine auxotroph, which means they
are dependent on thiamine uptake from the growth medium
(Supplementary Table 1). This enables direct external control
of the availability of this vitamin. Synthesis of TT-compounds
was achieved using a “click” chemistry approach utilizing a com-
mon azide intermediate, which was then further reacted with the
appropriate substituted alkyne yielding corresponding thiamine
analogs (Figure 2A, Supplementary Figure 1). Subsequent moni-
toring of β-galactosidase activity was performed in the presence
and absence of thiamine or triazolethiamine (TT) derivatives.
Addition of thiamine to the E. coli cultures resulted in a complete
loss of β-galactosidase expression; an IC50-value of 0.015μM
was observed (Figure 2 and Table 1). In line with previous find-
ings, pyrithiamine (PT) was shown incapable of β-galactosidase
repression in DH5αZ1 (Figure 2B) (Sudarsan et al., 2005). On
the other hand, the addition of 500μM TT (1) represses the
expression of β–galactosidase expression to a level similar to
that of thiamine. TT has been shown to depend on diphos-
phorylation to gain activity in vitro (Chen et al., 2012). Thus,
we anticipate that TT is phosphorylated by the endogenous set
of thiamine converting enzymes. Shortening (2) or elongating
the alkyl side chain (3 and 4, Figure 1A) results in a loss of
repression with increasing deviation from the natural alkyl chain
length (Figure 1B). This is most likely due to reduced uptake
and/or phosphorylation of these compounds, but could also be
because of a poor fit of phosphorylated triazolethiamines to the
riboswitch. Previously, it has been shown that the thi-box aptamer
domain is somewhat adjustable to ligand size through com-
paction of pyrimidine and phosphate sensor helices (Edwards and
Ferre-D’Amare, 2006). However, this low affinity ligand binding
[thiamine KD = 50μM vs. TPP KD = 50 nM, (Sudarsan et al.,
2005)] is unlikely to efficiently induce subsequent changes in the
expression platform (Serganov et al., 2006) and thus reporter gene
expression. Interestingly, compound 5, which bears an amino
group instead of a hydroxyl residue on the ethyl-alkyl side chain
of TT, also represses reporter gene activity. How this compound
would be activated through in vivo phosphorylation is unclear.
However, it is possible that 5 is also phosphorylated in the same
way as TT. Experiments using a mutant version of the thiM
riboswitch (thiM-Mu, Figure 1A), which is incapable of binding
to TPP showed that neither of the investigated TT-compounds
represses gene expression in these assays. These data under-
line that repression of gene expression truly relies on riboswitch
binding and activation. We next measured IC50-values of these
compounds, to evaluate concentration dependent repression of
gene expression. TT (1) revealed the strongest effect with an
IC50-value of 8.4μM (Table 1 and Supplementary Figure 2).
Compounds with increasing alkyl-chain length (3 and 4) showed
no concentration dependent inhibition curves (Table 1) and, as
expected for this bacterial strain, PT did not show an effect on
β-galactosidase expression (Table 1, Figure 2A). In order to inves-
tigate the dependence of TT activity on endogenous proteins and
enzymes involved in thiamine biosynthesis, several strains of the
Keio collection were investigated, that all originate from the strain
BW25113, and contain deletions of non-essential genes known to
be involved in thiamine metabolism of E. coli (Scheme 1) (Baba
et al., 2006).
Thiamine is synthesized from two precursors, hydroxy/-
methyl/-pyrimidine diphosphate (HMP-PP) and hydroxyethylth-
iazole phosphate (HET-P), which are produced independently
and finally joined to form thiamine phosphate (Begley et al.,
1999). Further phosphorylation yields the cofactor TPP
(Scheme 1). The Keio deletion strains were transformed with
the β-galactosidase reporter plasmid containing either the wild
type or the mutant TPP-riboswitch and effects of thiamine,
TT or PT on reporter gene expression were assayed (Table 2,
Figure 3, Supplementary Figures 9, 10). In most strains the
addition of thiamine led to a strong decrease in β-galactosidase
expression that is comparable to that observed for the wild
type strain. As expected, the thiK deletion strain (thiK)
revealed decreased thiamine sensitivity, since this enzyme is
required for the phosphorylation of thiamine to TPP. When
adding thiamine, thiI and iscS deletion strains showed slightly
increased levels of reporter gene expression indicating a loss
of TPP-riboswitch activation (Figure 3A). Investigating the
impact of TT (Figure 3B) on TPP-riboswitch dependent reporter
gene expression in the deletion strains revealed a prominent
increase in reporter gene expression for those strains containing
deletions of thiamine transport genes (Scheme 1; thiP, thiQ,
tbpA) in comparison to wild type cells (Figure 3B, magenta bars).
This may indicate that TT uptake is, at least in part, mediated
Table 1 | IC50-values of thiamine, pyrithiamine and compound 1–5 for
inhibition of reporter gene expression in DH5αZ1 cells are listed.
Compound IC50 (μM) (DH5αZ1) 95% Confidence interval
Thiamine 0.015 0.012–0.019
1 (TT) 8.4 4.6–15.6
2 43.3 13.4–140
3 n.a. n.a.
4 n.a. n.a.
5 22.9 12.1–43.4
PT n.a. n.a.
Means and 95% confidence intervals of at least three independent experiments,
measured in duplicates, are shown. n.a., not applicable; where data points could
not be fitted to a dose-response curve. TT, Triazolethiamine; PT, Pyrithiamine.
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by these ABC-transporters. However in the presence of PT,
reporter gene expression in these strains was scarcely increased
in comparison to the wild type strain (Figure 3C). This suggests
that PT, just like thiamine (Figure 3A), must use other routes
of cell entry apart from the thiamine-specific active transporter.
Possibly, its positive charge supports passive diffusion processes,
as believed to occur for thiamine as well (Webb et al., 1998).
Besides the dependence on transport proteins, differential effects
on several other deletion strains involved in phosphate-transfer
or thiazole formation were observed (Figure 3, green and
gray bars, respectively). Assaying thiK, thiD, and thiM,
strains, whose deleted genes are involved in phosphate transfer
reactions, revealed increased β-galactosidase expression in the
presence of TT compared to wild type, whereas thiE showed
decreased β-galactosidase expression (Figure 3B). As the deletion
of thiE renders the bacteria incapable of synthesizing any TPP
from its HMP and HET precursors (Scheme 1), the reporter
gene expression is mainly influenced by external thiamine or
compound supply. Interestingly, the prominent decrease of
β-galactosidase expression in the presence of TT is comparable
to that found for thiamine at the same concentration in the
wild type strain BW25113 (Figure 3A, black bars). In thiE
cells, lower intracellular concentrations of thiamine compete
for any possible enzymatic TT-activation mechanism (such as
SCHEME 1 | Biosynthesis of TPP in E. coli is accomplished by the
separate synthesis of the pyrimidine and thiazole moiety, which are
finally coupled and phosphorylated to form TPP (Begley et al., 1999). The
biosynthesis of the pyrimidine part of thiamine starts with an intermediate of
the purine biosynthesis pathway, namely aminoimidazole ribotide (AIR). The
thiamine biosynthesis protein ThiC whose exact function remains to be
elucidated, converts AIR to hydroxymethylpyrimidine-phosphate (HMP-P),
which is subsequently phosphorylated by the bifunctional HMP/ HMP-P
kinase ThiD to yield hydroxymethyl-pyrimidine pyrophosphate (HMP-PP). The
thiazole moiety of thiamine is derived from tyrosine, cysteine and 1-deoxy-D-
xylulose phosphate (DXP). In a yet unresolved chain of reactions featuring
thiF, thiS, thiG, thiH and thiI gene products, hydroxyethyl-thiazole phosphate
(HET-P) is formed. HMP-PP and HET-P are joined by one enzymatic step
mediated by the ThiE protein, followed by phosphorylation of the formed
TMP by ThiL to create TPP. Three distinct kinases, ThiM, ThiD, and ThiK, are
involved in the salvage of HET, HMP, and thiamine, respectively, from the
culture medium. Thiamine, thiamine phosphate, and thiamine pyrophosphate
are actively transported in enteric bacteria using the ABC transport system
ThiBPQ (Webb et al., 1998). At present, no other distinct thiamine
transporters, neither HET nor HMP transport systems, have been identified in
bacteria (Rodionov et al., 2002). Essential genes are colored red, gray genes
are not validated in E. coli.
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phosphorylation or take-up). Therefore, the same amounts of
TT lead to a stronger decrease of reporter gene expression in
these cells in comparison to other deletion strains (Figure 3B).
In the presence of TT, thiC and iscS deletion strains which are
involved in formation of the thiazole moiety of thiamine revealed
increased β-galactosidase expression (Figure 3B). At the same
time β-galactosidase expression in thiI, thiG, thiH and sufS
deletion strains remained unaffected or was slightly decreased
in the presence of PT (Figure 3C). Finally, PT-treated E. coli
strains containing deletions of the genes thiD and thiC, which
are involved in the biosynthesis of the pyrimidine-containing
precursor HMP-PP (Scheme 1), show an increase in reporter
gene expression (Figure 3C). The same is observed for the thiE
strain. The deletion of iscS renders bacteria less susceptible to
thiamine, TT or PT (Supplementary Figure 3). However, it
should be noted that the iscS strain showed slower growth than
any of the other deletion strains investigated. This reduced fitness
may be due to the fact that ThiI and IscS are not only involved
in thiamine metabolism but also needed in the 4-thiouridine
biosynthetic pathway (Scheme 1). Interestingly, deleting the
thiamine kinase ThiK abolished thiamine and TT dependent
inhibition of reporter gene expression (Figures 3A,B). This
finding underlines the hypothesis that TT is only active in vivo
in its phosphorylated form. Due to its close structural similarity
to the natural substrate thiamine, TT is likely to be recognized
and phosphorylated by endogenous bacterial enzymes such as
ThiK. Using ITC measurements Chen and colleagues revealed
that the chemically synthesized, diphosphorylated form of TT,
Table 2 | IC50-values of thiamine for inhibition of reporter gene
expression in E. coli containing the indicated deletion of a
non-essential thiamine biosynthesis gene are shown as mean and
95% confidence interval of at least three independent experiments,
measured in duplicates.
Strain IC50 (μM) 95% Confidence Interval
BW25113 (wt) 0.032 0.022–0.047
thiP 0.93 0.74–1.2
thiQ 1.5 1.0–2.1
tbpA 1.3 0.97–1.7
thiL 0.027 0.018–0.039
thiK n.a. n.a.
sufS 0.025 0.018–0.036
thiD 0.019 0.012–0.030
thiM 0.016 0.010–0.026
iscS n.a. n.a.
thiH 0.028 0.021–0.037
thiS 0.033 0.018–0.061
thiF 0.009 0.0062–0.013
thiE 0.071 0.045–0.11
thiC 0.023 0.015–0.035
thiG 0.0091 0.0054–0.015
n.a., not applicable, where data points could not be fitted to a dose-response
curve.
Respective curves are shown in Supplementary Figures 9, 10.
named triazolethiamine pyrophosphate (TTPP), binds to the
thiM (Figure 4A) riboswitch with an affinity of 370 nM, whereas
for the natural ligand TPP a KD of 8 nM was measured (Chen
et al., 2012). Additionally, in vitro translation assays proved that
binding of TTPP induces a change in riboswitch secondary struc-
ture to sequester the SD-sequence and inhibits efficient protein
translation (Chen et al., 2012). Therefore, endogenous diphos-
phorylation of TT would generate a very potent TPP-riboswitch
activator. Hence, we were intrigued to find that reporter gene
expression for the thiK deletion strain is dramatically decreased
in the presence of PT (Figure 3C). This suggests that PT either
does not need to be activated by pyrophosphorylation through
FIGURE 3 | Effect of thiamine (A), triazolethiamine (B) or pyrithiamine
(C) on reporter gene expression in BW25113 (black bars) and BW25113
strains with the indicated deletion. Minimal medium was supplemented
with 500μM of thiamine (T), TT or PT. magenta bars: thiamine transport
genes; green bars: phosphorylation enzymes; gray bars: genes involved in
thiazole formation.
www.frontiersin.org July 2014 | Volume 2 | Article 53 | 5
Lünse et al. Riboswitch activators
ThiK, that it can also be phosphorylated by other endogenous
enzymes like ThiE or that it is converted into TPP through
salvage pathways.
In order to bypass ThiK-dependency of TT activity in
E. coli, triazolethiamine derivatives that were intended to be
independent of endogenous phosphorylation were synthesized
and their impact on riboswitch regulation of β-galactosidase
expression was studied. These compounds contain a number of
phosphate mimics (sulfate, sulfonamide, and sulfone) and metal-
chelating groups (dicarbonyl compounds) that might be expected
to interact with phosphate-binding metal ions in proteins
(Supplementary Figures 4–8). A “click” chemistry approach was
used to generate sulfone 7 and the methotrexate- or folate- like
compounds 15 and 16 (Figure 4A). Amide couplings were per-
formed to obtain the sulfonamides 8 and 9 and also to obtain
the pyruvate, malonate and salicylic acid containing compounds
10, 11, and 12, respectively (Figure 4A) (Erixon et al., 2008).
Additionally, a Michael addition was used to generate the sulfones
13 and 14. With respect to the phosphate mimics, the sulfon-
amide 13 and the sulfone 14 that are connected to a benzyl group
scarcely activate the thiM riboswitch in DH5αZ1 cells. The sul-
fonamide 8 had a similar effect on β-galactosidase expression in
the thiamine auxotroph strain. Interestingly, compounds contain-
ing the planar benzene ring are not as active in thiM riboswitch
activation, even though it is imaginable that this aromatic ring
could tighten compound-riboswitch interaction by π-π-stacking
with RNA nucleobases (Edwards and Ferre-D’Amare, 2006;
FIGURE 4 | Chemical formulas of triazole thiamine analogs with
phosphate mimicking groups (A). Relative β-galactosidase expression in
the presence of thiamine or compound (500μM) in DH5αZ1 cells is
shown (B).
Thore et al., 2006). Compounds 15 and 16 were found to be the
most potent repressors of reporter gene expression (Figure 4B,
∼0.5 fold β-galactosidase expression). Compounds of this group
have enough flexibility in principle to interact with twometal ions
via their ester or carboxyl groups. Interestingly, these molecules
activate the thiM riboswitch extensively, despite their relatively
large size. The carboxylate ethyl esters like 15 are likely to enter
the cell passively and are probably hydrolyzed by esterases result-
ing in 16. To investigate whether the most potent phosphate
mimics exhibit a ThiK independent reduction in reporter gene
expression, compounds 7 and 16 were chosen and assayed in the
thiamine kinase deficient E. coli strain (Figure 5A). In contrast
to addition of thiamine or TT, which do not reduce reporter
gene expression, the addition of the same amount of 7 and 16
induces a decrease of β-galactosidase expression to approximately
FIGURE 5 | Effect of thiamine, TT, PT and phosphate mimics 7 and 16
on β-galactosidase expression in E. coli strains thiK (A), BW25113
(B), and thiP (C). Minimal medium (refer to experimental procedures for
details) was supplemented with 500μM of analyte. Compound 16 was
dissolved to a stock solution of 100mM in 100% DMSO, assay controls also
contained a final DMSO concentration of 1%.
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0.25 fold (Figure 5A). However, thiK strains transformed by
the mutated thiM riboswitch construct do not or only slightly
respond to thiamine or compound addition (Supplementary
Figure 11A). In wild type E. coli strain BW25113 thiamine has the
strongest influence on β-galactosidase repression. TT and com-
pound 7 are almost as efficient in inhibiting gene expression
whereas PT and compound 16 show somewhat weaker effects
(Figure 5B). Again no significant influence on reporter gene
expression in cells containing the mutant thiM riboswitch was
observed (Supplementary Figure 11C). Investigating the deletion
of one subunit of the active thiamine transporter (ThiP) revealed
increased levels of reporter protein for TT, 7, and 16, indicating
that these molecules are at least in part taken-up via this mech-
anism (Figure 5C). The investigation of the mutant riboswitch
construct thiM-Mu proves these compound effects to be specific
for thiM riboswitch activation, as the mutated RNA does not alter
protein expression (Supplementary Figure 11).
DISCUSSION
TPP riboswitch are interesting and attractive target structures for
developing antibacterial compounds. They form the most exten-
sive riboswitch class with representatives found in bacteria, archea
and plants (Kubodera et al., 2003; Sudarsan et al., 2003; Bocobza
et al., 2007). Here we show that replacing the thiazole heterocy-
cle with 1,2,3-triazole is a valuable strategy to generate thiamine
analogs that interact with TPP riboswitches and, thus, induce
repression of gene expression. These findings are in line with the
observations of Chen al. recently reporting that the diphosphory-
lated triazolethiamine indeed interacts with the thiM riboswitch
in vitro, albeit with decreased affinity (Chen et al., 2012). We went
a significant step further and demonstrated that these compounds
are effective in E. coli and, more importantly, that their activ-
ity depends on proteins involved in the metabolic pathways of
thiamine uptake and synthesis.
The data shown above indicate that activity of TT depends
on active uptake and endogenous phosphorylation by ThiK.
Surprisingly, PT was found to be independent of ThiK and trans-
porters. Therefore, PT is either phosphorylated by other kinases
apart from ThiK or its phosphorylation, against all previous
hypotheses, is not necessary for in vivo activity (Edwards and
Ferre-D’Amare, 2006; Warner et al., 2014). Unphosphorylated
PT is known to have a more than 1000 fold lower affinity for
the TPP-riboswitch, whereas diphosphorylation results in a KD
that is only 3fold higher than that of TPP (Sudarsan et al.,
2005). Although PT was shown to bind to the pyrimidine sen-
sor helix of the aptamer domain by one hydrogen bond and the
stacking of the aminopyrimidine ring, crystal structures revealed
that two hydrogen bonds have been lost in comparison to TMP
or TPP interactions. The pyrophosphate sensor helix is largely
disordered and it is questionable whether this riboswitch con-
formation allows gene regulation upon PT binding (Edwards
and Ferre-D’Amare, 2006). Furthermore, the increase in thiM-
riboswitch dependent reporter gene expression in the presence
of PT in thiD or thiC strains suggests the existence of a PT-
detoxification mechanism in E. coli as proposed for B. subtilis by
Sudarsan et al. (2005). If indeed there was a thiaminase-II-like
enzyme present in E. coli, HMP could be recovered from PT
and used for the generation of thiamine through combination
with de novo synthesized thiazole (Scheme 1). This PT recycling
would lead to a decrease of its intracellular concentration, hence
a diminished influence on the TPP-riboswitch-dependent gene
expression. At the same time, the newly generated TPP is likely to
be used immediately for its biological purpose without accumu-
lation and hence a need for riboswitch-mediated down regulation
of gene expression. Even though a TenA-like protein has not yet
been identified in E. coli, in silico predictions indicate that ThiC
may represent a functional equivalent of TenA (Morett et al.,
2003).
We further show that equipping TT with metal-chelating
groups results in ThiK- and transport-independent activity. This
indirectly proves that TT requires phosphorylation and indicates
a possible route in riboswitch activator design which circum-
vents the necessity of endogenous proteins and renders riboswitch
inhibitors independent of bacterial pathways. The most promis-
ing phosphate-mimics were tested for their dependence on ThiK
or active thiamine transport mechanisms. Whereas activity of
compound 16 appears to be ThiK-independent, its transport is
strongly influenced by ABC transporter integrity. At the same
time, effects of compound 16 in wild type cells are not as promi-
nent as those observed for TT. Compound 7 however, does
not only reveal strong reporter gene repression, but this effect
is even independent of ThiK or ThiP presence. Hence, future
compound designs should take characteristics of compound 7
into account in order to provide novel chemical entities whose
in vivo activity does not depend on the individual enzyme reper-
toire of the target cell. Also, investigating potential routes of
metabolism of phosphate-mimicking compoundsmay unveil fur-
ther information and support the generation of evenmore precise
riboswitch-regulating compounds.
The distinct efficiencies of TT-derivatives and PT in repres-
sion of gene expression, further point at possible secondary
effects of the employed metabolite analogs. These side effects
may rely on interactions with enzymes involved in thi-
amine pyrophosphate metabolic pathways. Indeed it has been
shown that triazole-derivatives of thiamine pyrophosphate
inhibit enzymes involved in the biosynthesis of TPP in vitro
(Erixon and Dabalos, 2007).
Others have shown that analogs with a positively charged mid-
dle ring bind much better to the thiM riboswitch than ones
with a neutral ring at this position (Chen et al., 2012). It was
suggested that this is due to the electron drawing effect of the
middle ring, which enhances the binding of the pyrimidine moi-
ety to the cognate part of the aptamer domain. The reporter
gene assay presented herein however suggests that in vitro bind-
ing does not always necessarily correlate with in vivo riboswitch
regulation. Even though TT does not contain a charged middle
ring, it induces reporter gene repression more efficiently than PT.
Moreover, our study shows that riboswitch regulation by artifi-
cial activators is dependent on the individual set of metabolic
enzymes present in the organism.
Since TT (1) is active in E. coli and reveals superior activity
when compared to pyrithiamine it represents a very promising
starting point for developing novel antibacterial compounds that
target TPP-riboswitches. Furthermore, our study shows that even
www.frontiersin.org July 2014 | Volume 2 | Article 53 | 7
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being very similar from a structural point of view, TT and PT
engage diverse endogenous mechanisms to attain activity. These
findings are of importance for the design and understanding of
compounds that require intracellular activation to achieve an
effective repression of gene expression.
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